Ascenion’s parent company, the LifeScience Foundation for the Promotion of Science and Research, has provided funding of nearly EUR 0.5 million for the Fr1da study at the Institute of Diabetes Research, Helmholtz Zentrum München.
Scientists and physicians hope to improve the screening and optimal treatment of type 1 diabetes in children. Using…
Ascenion’s portfolio company OMEICOS reported positive Phase I data for its lead candidate OMT-28, a small molecule with strong anti-arrhythmic and cardioprotective potential. The study, which enrolled 75 subjects at two centers in Germany, showed an excellent safety profile with no signals in vital signs or relevant laboratory parameters up to…
BioFIT is a partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences with more than 1,200 international delegates from 35+ countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed, seed and Series-A investors, as well as…
Ralf Cordes has more than 17 years of experience in technology transfer and has worked on numerous licensing, cooperation and spin-off projects for Ascenion since 2006.
He studied at the Friedrich-Alexander-Universität Erlangen-Nürnberg, specializing in developmental biology, and received his doctorate in molecular biology from the…
Elisabeth von Weizsäcker is an experienced entrepreneur who also brings expertise from 16 years in management consultancy to Ascenion. She has accompanied numerous biotech start-ups during their founding and financing, and has advised public sector organizations in strategic, organizational and commercial matters.
Before joining Ascenion, she and…
Elisabeth von Weizsäcker is an experienced entrepreneur who also brings expertise from 16 years in management consultancy to Ascenion. She has accompanied numerous biotech start-ups during their founding and financing, and has advised public sector organizations in strategic, organizational and commercial matters.
Before joining Ascenion, she and…
Thieß Gert Matzke has years of professional experience in legal issues relevant to technology transfer, from structuring and negotiating complex licensing contracts, to research cooperation agreements and university spin-off financing deals.
Prior to joining Ascenion in 2002, he was a lawyer at Beiten Burkhardt Mittl & Wegener,…
Thieß Gert Matzke has years of professional experience in legal issues relevant to technology transfer, from structuring and negotiating complex licensing contracts, to research cooperation agreements and university spin-off financing deals.
Prior to joining Ascenion in 2002, he was a lawyer at Beiten Burkhardt Mittl & Wegener,…
